4//SEC Filing
Getz Heather C 4
Accession 0000899243-21-006176
CIK 0001574774other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:49 PM ET
Size
26.3 KB
Accession
0000899243-21-006176
Insider Transaction Report
Form 4
Getz Heather C
SVP - CFO
Transactions
- Disposition to Issuer
Stock Options (Right to Buy)
2021-02-09$63.32/sh−23,578$1,492,959→ 0 totalExercise: $8.68Exp: 2024-02-14→ Common Stock (23,578 underlying) - Disposition to Issuer
Stock Options (Right to Buy)
2021-02-09$62.43/sh−22,455$1,401,866→ 0 totalExercise: $9.57Exp: 2026-02-15→ Common Stock (22,455 underlying) - Disposition to Issuer
Stock Options (Right to Buy)
2021-02-09$38.65/sh−18,991$734,002→ 0 totalExercise: $33.35Exp: 2028-02-14→ Common Stock (18,991 underlying) - Disposition to Issuer
Performance Stock Units
2021-02-09$72.00/sh−7,977$574,344→ 0 totalExercise: $0.00Exp: 2021-02-14→ Common Stock (7,977 underlying) - Disposition to Issuer
Common Stock
2021-02-09$72.00/sh−49,947$3,596,184→ 0 total - Disposition to Issuer
Stock Options (Right to Buy)
2021-02-09$61.64/sh−29,040$1,790,026→ 0 totalExercise: $10.36Exp: 2025-02-16→ Common Stock (29,040 underlying) - Disposition to Issuer
Stock Options (Right to Buy)
2021-02-09$47.35/sh−10,675$505,461→ 0 totalExercise: $24.65Exp: 2027-02-14→ Common Stock (10,675 underlying) - Disposition to Issuer
Stock Options (Right to Buy)
2021-02-09$18.78/sh−10,634$199,707→ 0 totalExercise: $53.22Exp: 2030-02-17→ Common Stock (10,634 underlying) - Disposition to Issuer
Performance Stock Units
2021-02-09$72.00/sh−1,987$143,064→ 0 totalExercise: $0.00Exp: 2022-02-14→ Common Stock (1,987 underlying) - Disposition to Issuer
Performance Stock Units
2021-02-09$72.00/sh−6,426$462,672→ 0 totalExercise: $0.00→ Common Stock (6,426 underlying)
Footnotes (4)
- [F1]Per the terms of the Agreement and Plan of Merger, dated as of December 18, 2020, among the Company, Philips Holding USA Inc., a Delaware corporation, and Davies Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock was validly tendered for $72.00 per share in cash (the "Offer Price"), less any applicable withholding taxes.
- [F2]Includes 21,390 restricted stock units that, pursuant to the Merger Agreement, were cancelled at the Effective Time of the Merger (both as defined in the Merger Agreement) and converted into the right to receive the Offer Price, less any applicable withholding taxes.
- [F3]Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the total number of shares of Company common stock subject to such stock option immediately prior to the Effective Time, and (ii) the excess, if any, of the Offer Price over the exercise price per share of such stock option, less applicable withholding taxes.
- [F4]Per the terms of the Merger Agreement, each performance stock unit ("PSU") that was outstanding as of the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash equal to the product of (i) the total number of shares of Company common stock subject to such PSU that would have vested if the applicable performance period ended immediately prior to the Effective Time (assuming that any applicable performance conditions were deemed to be achieved at the target performance level), multiplied by (ii) the Offer Price, less applicable withholding taxes.
Documents
Issuer
BIOTELEMETRY, INC.
CIK 0001574774
Entity typeother
Related Parties
1- filerCIK 0001481485
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 9:49 PM ET
- Size
- 26.3 KB